100 related articles for article (PubMed ID: 1380705)
1. Peripheral cardiovascular effects of tachykinins in conscious freely moving spontaneously hypertensive and Wistar Kyoto rats.
Pompei P; Tayebaty SJ; Massi M; de Caro G
Pharmacol Res; 1992; 25 Suppl 1():67-8. PubMed ID: 1380705
[No Abstract] [Full Text] [Related]
2. Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats.
Pompei P; Tayebati SJ; Polidori C; Perfumi M; De Caro G; Massi M
Peptides; 1993; 14(1):97-102. PubMed ID: 7680131
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological effects of tachykinin agonists on sympathetic ganglia of spontaneously hypertensive rats.
Tompkins JD; Hancock JC
Auton Neurosci; 2002 Apr; 97(1):26-34. PubMed ID: 12036183
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin release induced by intracranial injection of tachykinins is due to activation of central neurokinin-3 receptors.
Polidori C; Saija A; Perfumi M; Costa G; de Caro G; Massi M
Neurosci Lett; 1989 Sep; 103(3):320-5. PubMed ID: 2478934
[TBL] [Abstract][Full Text] [Related]
6. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin.
Andrews PV; Helme RD; Thomas KL
Br J Pharmacol; 1989 Aug; 97(4):1232-8. PubMed ID: 2477105
[TBL] [Abstract][Full Text] [Related]
7. Effects of tachykinins on the secretion of fluid and glycoproteins from the submandibular glands of rat, mouse, hamster and guinea pig.
Iwabuchi Y; Aoki C; Masuhara T
Jpn J Pharmacol; 1989 Nov; 51(3):428-31. PubMed ID: 2482911
[TBL] [Abstract][Full Text] [Related]
8. The central pressor actions of a novel tachykinin peptide, gamma-preprotachykinin-(72-92)-peptide amide.
Hagio T; Takano Y; Nagashima A; Nakayama Y; Tateishi K; Kamiya H
Eur J Pharmacol; 1991 Jan; 192(1):173-6. PubMed ID: 1710187
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of salt appetite in the rat following injection of tachykinins into the medial amygdala.
Massi M; Gentili L; Perfumi M; de Caro G; Schulkin J
Brain Res; 1990 Apr; 513(1):1-7. PubMed ID: 1693538
[TBL] [Abstract][Full Text] [Related]
10. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
Saigo A; Takano Y; Saito R; Nakayama Y; Honda K; Kamiya H
Regul Pept; 1993 Jul; 46(1-2):293-6. PubMed ID: 7692520
[No Abstract] [Full Text] [Related]
11. Blood pressure and heart rate responses to centrally administered substance P are increased in spontaneously hypertensive rats.
Unger T; Rockhold RW; Yukimura T; Rettig R; Ganten D
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():299s-302s. PubMed ID: 6160941
[TBL] [Abstract][Full Text] [Related]
12. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
[TBL] [Abstract][Full Text] [Related]
13. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
Tan DP; Tsou K
J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
[TBL] [Abstract][Full Text] [Related]
15. Ventilatory and cardiovascular actions of centrally administered trout tachykinins in the unanesthetized trout.
Le Mével JC; Lancien F; Mimassi N; Conlon JM
J Exp Biol; 2007 Sep; 210(Pt 18):3301-10. PubMed ID: 17766308
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro actions of mammalian tachykinins.
Holzer-Petsche U; Schimek E; Amann R; Lembeck F
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):130-5. PubMed ID: 2413373
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of tachykinin-induced bronchoconstriction in the rat.
Joos GF; Pauwels RA; van der Straeten ME
Am Rev Respir Dis; 1988 May; 137(5):1038-44. PubMed ID: 2461668
[TBL] [Abstract][Full Text] [Related]
18. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.
Januszewicz A; Loń S; Lapiński M; Styś A
J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Sun X; Edvinsson L; Hedner T
J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175
[TBL] [Abstract][Full Text] [Related]
20. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action.
Kalra PS; Sahu A; Bonavera JJ; Kalra SP
Endocrinology; 1992 Sep; 131(3):1195-201. PubMed ID: 1380435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
